Inventor · disambiguated record
Nicholas John Newcombe
Also filed as: NEWCOMBE NICHOLAS J · NEWCOMBE NICHOLAS JOHN
15 granted patents·9 pending applications·393 citations·filing 1997–2007
93Inventor score
Top patents by PatentIndex Score
24 records- 0195US6908920B2Pyrimidine derivativesASTRAZENECA AB·Filed 2001·Granted Jun 21, 2005·124 cites·10 claims
- 0293US6313127B1Heterocyclic compounds useful as pharmaceutical agentsZENECA LTD·Filed 1997·Granted Nov 6, 2001·139 cites·17 claims
- 0383US6969714B2Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferationASTRAZENECA AB·Filed 2001·Granted Nov 29, 2005·18 cites·15 claims
- 0479US6093718ASubstituted pyrimidine derivatives and their pharmaceutical useZENECA LTD·Filed 1997·Granted Jul 25, 2000·46 cites·11 claims
- 0575US6939872B22-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitorsASTRAZENECA AB·Filed 2002·Granted Sep 6, 2005·9 cites·12 claims
- 0671US6734183B2CompoundsASTRAZENECA AB·Filed 2001·Granted May 11, 2004·5 cites·20 claims
- 0770US7485638B2Pyrimidine compoundsASTRAZENECA AB·Filed 2003·Granted Feb 3, 2009·4 cites·12 claims
- 0867US7465728B2Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activityASTRAZENECA AB·Filed 2003·Granted Dec 16, 2008·3 cites·19 claims
- 0967US7122551B2Metalloproteinase inhibitor compoundsASTRAZENECA AB·Filed 2004·Granted Oct 17, 2006·2 cites·15 claims
- 1066US6734184B1Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)ASTRAZENECA AB·Filed 1999·Granted May 11, 2004·20 cites·14 claims
- 1162US7446105B2Pyrimidine compoundsASTRAZENECA AB·Filed 2003·Granted Nov 4, 2008·1 cites·12 claims
- 1262US7442697B24-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activityASTRAZENECA AB·Filed 2003·Granted Oct 28, 2008·1 cites·11 claims
- 1355US6335341B1Pyridyl-and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclaseZENECA LTD·Filed 1998·Granted Jan 1, 2002·18 cites·9 claims
- 1454US2006287338A1Metalloproteinase inhibitor compoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1553US7342020B2Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)ASTRAZENECA AB·Filed 2004·Granted Mar 11, 2008·0 cites·7 claims
- 1650US2006004033A1Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferationASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1746US2009118332A1Therapeutic Agents - 551ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1844US2011059941A12-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulatorsCAULKETT PETER WILLIAM RODNEY·Filed 2006·Application pending·0 cites
- 1943US2009105305A1Therapeutic Agents - 550ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2042US2009105263A1Heterobicyclic compounds as glucokinase activatorsCAULKETT PETER WILLIAM RODNEY·Filed 2006·Application pending·0 cites
- 2142US2007149560A1Novel fused triazolones and the uses thereofASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2240US6391880B1Heterocyclic compounds useful as oxido-squalene cyclase inhibitorsZENECA LTD·Filed 1998·Granted May 21, 2002·3 cites·11 claims
- 2339US2003100548A1Arylpiperazines and their use as metallaproteinase inhibiting agents (mmp)Filed 2001·Application pending·0 cites
- 2436US2003139419A1Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agentsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas John Newcombe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →